RECORD · 08 / ABOUT THIS CONSOLE
About Clinic CJC-1295
An independent editorial console that reads the published CJC-1295 record straight — what the studies measured, sourced line by line.
What this site is
Clinic CJC-1295 is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site reads the published record the way an enterprise data console reads a dataset: each finding logged as a record, each figure traceable to its source, the confirmed results and the open gaps marked with equal clarity. The point is to make a small, frequently-misrepresented literature legible — the 5.8-8.1 day DAC half-life, the GH and IGF-1 response, the DAC versus no-DAC distinction, and the halted Phase 2 program.
What 'clinic' means here
The word 'clinic' in the name is editorial framing — a position this publisher occupies relative to the literature, the measured register of a research console that examines evidence. It is not a claim about services. This site offers no treatment, no consultation, no prescription, and no diagnosis. There is no physical clinic, no clinical team, and no medical staff behind it.
We hold one editorial standard above the rest: every quantitative claim is tied to a citation, and the limits of the evidence are stated as plainly as the findings. CJC-1295 is an unapproved research chemical with a thin, short-term human dataset. Where the record is precise, this site is precise; where it is silent, this site says so.
How the record is assembled
The findings on this site come from peer-reviewed journals (Journal of Clinical Endocrinology & Metabolism, Endocrinology, Growth Hormone & IGF Research, Nature Reviews Endocrinology), the ClinicalTrials.gov registry, and the published regulatory record. Citations carry DOIs, PubMed IDs, and trial-registry identifiers so any reader can verify a claim independently.
We do not publish dosing recommendations, protocols, or anything resembling clinical guidance, and we do not sell or source the compound. The console is a reading of the literature — nothing more, and nothing less.